• Publications
  • Influence
Encountering Challenges with the EU Regulation on Advance Therapy Medical Products.
This article aims at analysing how well the Advanced Therapy Medical Product Regulation (EC) No. 1394/2007 (ATMP Regulation) meets the needs of small and medium-sized enterprises (SMES), academia andExpand
Commercialisation of Advanced Therapies : - A Study of the EU Regulation on Advanced Therapy Medical Products
Advanced therapy medicinal products (ATMPs), is a heterogeneous class of modern biotechnology medicines encompassing products based on genes (gene therapy medical products, GTMPs), cells (somaticExpand
Patentability of Parthenogenic Stem Cells: International Stem Cell Corporation v. Comptroller General of Patents.
The European Court of Justice (ECJ) has recently issued a ruling in Case C-364/13 International Stem Cell Corporation v. Comptroller General of Patents Designs and Tademarks (Case) that aims atExpand
Monoclonal biologics in acute myeloid leukemiaaml) therapy: translational strategies, policy, regulation and stakeholder engagement
Over 300 innovative biologic products have been tested for more than 200 diseases a pointer to the revolution in biotech companies to cure complex diseases. This surge in the development of biologicsExpand
Brüstle v. Greenpeace: Implications for Commercialisation of Translational Stem Cell Research.
  • Juli Mansnérus
  • Political Science, Medicine
  • European journal of health law
  • 16 March 2015
The lack of consensus on a common definition of the term 'embryo' has resulted in legal uncertainty affecting the permissibility of human embryonic stem cell (hESC) research and the commercialisationExpand
Personalized medicine: Legal and ethical challenges
The printed version of this title will be available on Unigrafia online store: https://shop.unigrafia.fi/?lang=en
Acute myeloid leukaemia - therapy - past, present and future
Acute myeloid leukemia (AML) is characterized by genetic aberrations and a variable response to therapy which has made treatment of AML challenging. The objective of this paper is to reviewExpand
Bioethical and legal perspectives on cell reprogramming technologies
Induced pluripotent stem cells (iPSCs) have been presented as a more ethical alternative to human embryonic stem cells (hESCs), which are surrounded by a significant ethical controversy. This articleExpand
Internet Banking : Risk management approach to e-banking and electronic money activities from financial institution´s point of view
The central objective of this study was to examine risks of e-banking and electronic money activities, such as credit card transactions from a financial institutions angle of view. My intention wasExpand